Toggle Navigation
EN
DE
Medicinal Cannabis – The Basics
Accessing Medicinal Cannabis
News & Events
About Althea
Contact Us
Concierge
Investor Centre
Investor Centre
Board
Management
ASX Announcements
News Releases
Governance
Financial Reports
Contact
ASX Announcements
2021
2020
2019
2018
Althea Reports 175% Revenue Growth For 1H FY2021
25 Feb 2021
Half Yearly Report and Accounts
25 Feb 2021
Peak Receives CAD$130K Initial Purchase Order From WeedMD
22 Feb 2021
Althea Completes First Shipment Of Products To Grow Pharma
11 Feb 2021
Althea Completes First Shipment Of Products To Germany
10 Feb 2021
Appendix 4C - quarterly
29 Jan 2021
Appendix 2A
29 Jan 2021
Change of Director's Interest Notice
29 Jan 2021
Successful Completion Of Share Purchase Plan
20 Jan 2021
December Sales Exceed $1.19M With 90% Monthly Growth in UK
11 Jan 2021
Appendix 2A
29 Dec 2020
Supply and Distribution Agreement for UK and Jersey
23 Dec 2020
Share Purchase Plan Offer Document
21 Dec 2020
Cleansing Notice
21 Dec 2020
Appendix 2A
21 Dec 2020
CBD Medicines Available For Over-The-Counter Sale From 2021
16 Dec 2020
Investor Presentation
15 Dec 2020
Proposed issue of Securities - AGH
15 Dec 2020
Althea Announces Capital Raising to Support Ongoing Growth
15 Dec 2020
Trading Halt
11 Dec 2020
Strong UK Sales Combine For Record Revenue In November
8 Dec 2020
Althea Expands Into South Africa With New Supply Agreement
3 Dec 2020
Peak To Manufacture US Cannabis Brand Tinleys In Canada
1 Dec 2020
Results of Meeting
26 Nov 2020
CEO's Address To Shareholders
26 Nov 2020
Investor Webinar on Peaks Fast Start Readying for Germany
18 Nov 2020
Althea Products Approved for Sale in Germany
18 Nov 2020
Peak Lifts Expected Revenue With Two New Agreements
16 Nov 2020
Appendix 2A and Appendix 3G
6 Nov 2020
Cleansing Notice
3 Nov 2020
Corporate Governance Statement
30 Oct 2020
Notice of Annual General Meeting/Proxy Form
22 Oct 2020
Appendix 4C - quarterly
15 Oct 2020
Ceasing to be a substantial holder
22 Sep 2020
Appendix 2A
21 Sep 2020
Health Canada Licence Granted - Peak Operations to Commence
14 Sep 2020
Notice of Release from Escrow
14 Sep 2020
Investor Webinar - Interim Decision to Down Schedule CBD
10 Sep 2020
CBD Products to Become Available Over the Counter
9 Sep 2020
Becoming a substantial holder
1 Sep 2020
Appendix 4G
27 Aug 2020
Annual Report to Shareholders
27 Aug 2020
Online Sales Drive Record Revenue in July
17 Aug 2020
Statement Pursuant to Listing Rule 4.7C
14 Aug 2020
Appendix 4C - quarterly
16 Jul 2020
Althea Launches Online Sales of Medicinal Cannabis Products
8 Jul 2020
MyAccess Clinics Enters Drug Science Project Twenty21
24 Jun 2020
Peak Signs Production Agreement With Collective Project
22 Jun 2020
Response to Appendix 3Y Query
27 May 2020
Althea Executes Germany Supply And Distribution Agreement
1 May 2020
Appendix 4C - quarterly
15 Apr 2020
Final Evidence Package Submitted to Health Canada - Updated
7 Apr 2020
Final Evidence Package Submitted to Health Canada
6 Apr 2020
Significant Progress Across Australia, UK and Canada
30 Mar 2020
Extension of Voluntary Escrow
23 Mar 2020
Change of Director's Interest Notice
20 Mar 2020
Ceasing to be a substantial holder from PDL
17 Mar 2020
Half Yearly Report and Accounts
26 Feb 2020
Strong Patient Growth in January
11 Feb 2020
Investor Presentation
29 Jan 2020
Appendix 4C - quarterly
29 Jan 2020
Althea Exceeds 4000 Patients with 48% Month on Month Growth
7 Jan 2020
Whistleblower Policy
27 Dec 2019
Althea approaching 4,000 patients in Australia
17 Dec 2019
Results of Meeting
27 Nov 2019
2019 AGM CEO Address
27 Nov 2019
Althea Passes 3,000 Patient Milestone
15 Nov 2019
MyAccess Clinics Secures Licence with UK Health Regulator
14 Nov 2019
Althea to Supply Product for Clinical Trial
13 Nov 2019
Althea Commences German Market Entry
12 Nov 2019
Notice of Annual General Meeting/Proxy Form
30 Oct 2019
Becoming a substantial holder from PDL
29 Oct 2019
Althea Launches New Full Spectrum CBD Product
28 Oct 2019
Change in substantial holding
28 Oct 2019
Change of Director's Interest Notice
25 Oct 2019
Change of Director's Interest Notice
25 Oct 2019
Change of Director's Interest Notice
25 Oct 2019
Althea Extends Product Supply Agreement Until 2027
25 Oct 2019
Trading Halt
23 Oct 2019
Pause in Trading
23 Oct 2019
Change of Director's Interest Notice
22 Oct 2019
Change of Director's Interest Notice
22 Oct 2019
Appendix 3B
22 Oct 2019
Cleansing Notice
22 Oct 2019
Althea Completes Acquisition of Peak Processing Solutions
18 Oct 2019
Appendix 4C, Market Update and Peak Processing LOI
16 Oct 2019
Results of Meeting
14 Oct 2019
Chairman's Address to Shareholders (Peak Acquisition)
14 Oct 2019
Althea Reaches 2329 Patients After Record Month
4 Oct 2019
Change in substantial holding
25 Sep 2019
Waiver of ASX Listing Rules 7.3.2 and 10.13.3
18 Sep 2019
Notice of General Meeting
18 Sep 2019
Investor Presentation
11 Sep 2019
Investor Update
9 Sep 2019
Change of Director's Interest Notice
27 Aug 2019
Annual Report to shareholders
22 Aug 2019
Appendix 4G
22 Aug 2019
Cleansing Notice
12 Aug 2019
Appendix 3B
9 Aug 2019
Althea Reaches 1523 Patients after Record Month
7 Aug 2019
Althea Supplies First UK Patient
1 Aug 2019
Appendix 4C - quarterly
25 Jul 2019
Investor Presentation
25 Jul 2019
Reinstatement to Official Quotation
25 Jul 2019
Acquisition and Capital Raising
25 Jul 2019
Voluntary Suspension from Official Quotation
24 Jul 2019
Trading Halt
19 Jul 2019
Althea to Supply Product for First UK Medical Cannabis Pilot
25 Jun 2019
First UK Prescription and Facility Planning Permit
21 Jun 2019
Althea Achieves 1,000 Patient Milestone
14 Jun 2019
PAC Partners Hong Kong Conference Presentation
12 Jun 2019
Althea Granted Hemp Licence
5 Jun 2019
Althea Launches Concierge UK Platform
31 May 2019
Securities Dealing Policy
17 May 2019
Investor Update
29 Apr 2019
Details of Company Address
15 Apr 2019
Company Secretary Appointment
15 Apr 2019
Appendix 4C - quarterly
4 Apr 2019
Change of Director's Interest Notice
25 Mar 2019
Change of Director's Interest Notice
21 Mar 2019
Investor Update
7 Mar 2019
Final Director's Interest Notice
7 Mar 2019
Director Appointment and Resignation
7 Mar 2019
Half Year Accounts and Report
28 Feb 2019
Appendix 4D
28 Feb 2019
Product Supply and Distribution Agreement with Cannvalate
21 Feb 2019
MEDIC Education Portal
14 Feb 2019
Althea expands into the UK
7 Feb 2019
Appendix 4C - Quarterly
31 Jan 2019
Althea reaches 300 patient milestone
25 Jan 2019
Althea receives largest shipment of inventory
20 Dec 2018
Investor Presentation - December 2018
10 Dec 2018
Initial Director's Interest Notice
6 Dec 2018
Results of Meeting
30 Nov 2018
CEO Address to Shareholders
30 Nov 2018
Change of Director's Interest Notice
23 Nov 2018
Althea granted Export Licence
13 Nov 2018
Althea granted Manufacture Licence
2 Nov 2018
Notice of Annual General Meeting/Proxy Form
30 Oct 2018
Appendix 4C - quarterly
24 Oct 2018
Althea reaches 100 patients
18 Oct 2018
Althea appoints cannabis distributor
10 Oct 2018
Althea appoints Chief Financial Officer and General Counsel
27 Sep 2018
Becoming a substantial holder
21 Sep 2018
Becoming a substantial holder
21 Sep 2018
Becoming a substantial holder
21 Sep 2018
Becoming a substantial holder
21 Sep 2018
Initial Director's Interest Notice
21 Sep 2018
Initial Director's Interest Notice
21 Sep 2018
Initial Director's Interest Notice
21 Sep 2018
Initial Director's Interest Notice
21 Sep 2018
Althea completes fund raising for ASX IPO
21 Sep 2018
Securities Dealing Policy
20 Sep 2018
Long Term Incentive Plan
20 Sep 2018
Audited FY2018 Accounts- Althea Company Pty Ltd
20 Sep 2018
Audited FY2018 Accounts- AGH
20 Sep 2018
Constitution
20 Sep 2018
Information Form and Checklist
20 Sep 2018
Appendix 1A
20 Sep 2018
Pre-quotation Disclosure (includes top 20 & distribution)
20 Sep 2018
ASX Market Announcement- Admission and quotation
19 Sep 2018
Replacement Prospectus
19 Sep 2018
Latest Announcements
Althea Reports 175% Revenue Growth For 1H FY2021
25 Feb 2021
Half Yearly Report and Accounts
25 Feb 2021
Peak Receives CAD$130K Initial Purchase Order From WeedMD
22 Feb 2021
Althea Completes First Shipment Of Products To Grow Pharma
11 Feb 2021
Althea Completes First Shipment Of Products To Germany
10 Feb 2021
Healthcare Professional Resource Centre
The following information has been developed for Healthcare Professionals only and not for the general public. By accessing the information, you confirm that you are a registered Healthcare Professional.
Continue